| C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer | |
| Wu, Songyang; He, Hongyong; Liu, Hao; Cao, Yifan; Li, Rochen; Zhang, Heng; Li, He; Shen, Zhenbin; Qin, Jing; Xu, Jiejie | |
| 刊名 | ONCOIMMUNOLOGY
 |
| 2018 | |
| 卷号 | 7期号:6 |
| 关键词 | adjuvant chemotherapy C-C motif chemokine 22 gastric cancer prognosis tumor microenvironment |
| ISSN号 | 2162-402X |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3608373 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Wu, Songyang,He, Hongyong,Liu, Hao,et al. C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer[J]. ONCOIMMUNOLOGY,2018,7(6). |
| APA | Wu, Songyang.,He, Hongyong.,Liu, Hao.,Cao, Yifan.,Li, Rochen.,...&Xu, Jiejie.(2018).C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.ONCOIMMUNOLOGY,7(6). |
| MLA | Wu, Songyang,et al."C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer".ONCOIMMUNOLOGY 7.6(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论